What's new? Log in Free sign up

Filing search / scPharmaceuticals Inc. / "Leadership"

Search information

scPharmaceuticals Inc.

Companies

"Leadership"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

19 results

Newest first Best match first

SCPH scPharmaceuticals Inc.

Definitive proxy

Stockholder Communications Board Leadership Structure and Board's Role in Risk Oversight Risks Related to Compensation Policies and Practices Board Committees … . Schaeffer is qualified to serve on our board of directors because of his industry experience and his decades-long track record of serving in leadership

26 Apr 24

4:16pm

SCPH scPharmaceuticals Inc.

Preliminary proxy

Stockholder Communications Board Leadership Structure and Board's Role in Risk Oversight Risks Related to Compensation Policies and Practices Board … is qualified to serve on our board of directors because of his industry experience and his decades-long track record of serving in leadership positions

SCPH scPharmaceuticals Inc.

leadership team strongly support this focus. Corporate Information We were formed as a limited liability company under the laws of the State of Delaware … concerns could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed

13 Mar 24

4:16pm

SCPH scPharmaceuticals Inc.

Definitive proxy

Director Nominees Minimum Qualifications Stockholder Recommendations Stockholder Communications Board Leadership Structure and Board's Role in Risk Oversight … that Mr. Khattar’s leadership, executive, managerial, business and pharmaceutical company experience, along with his more than 30 years of industry

27 Apr 23

4:18pm

SCPH scPharmaceuticals Inc.

Definitive proxy

Board Leadership Structure and Board's Role in Risk Oversight Risks Related to Compensation Policies and Practices Board Committees Audit Committee … of the University of Pennsylvania. We believe that Mr. Khattar’s leadership, executive, managerial, business and pharmaceutical company experience, along

28 Apr 22

4:00pm

22 Mar 22

4:01pm

Definitive proxy

27 Apr 21

4:00pm

vln6exrtot9sqr4g

23 Mar 21

5:12pm

i7009t ve5yjq9mtym1

Quarterly report

16 Nov 20

8:00am

Quarterly report

13 Aug 20

4:00pm

h0759w102hsjbcx

Provides Business Update

Departure of Directors or Certain Officers

Prospectus supplement for primary offering

ksb586 uh2atc0v0tg0c

Prospectus supplement for primary offering

Quarterly report

12 May 20

4:03pm

Definitive proxy

27 Apr 20

4:00pm

Definitive proxy

30 Apr 19

4:18pm

Departure of Directors or Certain Officers

dw5bpff3yih05srs

Definitive proxy

Prev
1
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.